Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-PHENO-25176

Xla Wt + hbg1 cMO, Melchert J et al. (2020)

Experiment + Assay: Xla Wt + hbg1 cMO + WE NF35/36 (RNA-Seq (RNA))
Background: Xla.Outbred
Manipulations:
Manipulation Type Reagent Target Gene Stage Treatment Area
morpholino injection   hbg1 (Xla)
 NF stage 4 (8-cell) blastomere
Conditions:
Assay Type Assay Stages Antibody
RNA-Seq NF stage 35 and 36  
Expression Phenotypes (2):
increased amount ghrh.L expression in the embryo
decreased amount nd4.L expression in the embryo
GEO Series: GSE126058: Xenbase, NCBI
Article: XB-ART-56559, PubMed